Abstract

Colorectal cancer is the second most common cancer diagnosed in men and the third most commonly occurring in women worldwide. Interactions between cells and the surrounding extracellular matrix (ECM) are involved in tumor development and progression of many types of cancer. The organization of the ECM molecules provides not only physical scaffoldings and dynamic network into which cells are embedded but also allows the control of many cellular behaviors including proliferation, migration, differentiation, and survival leading to homeostasis and morphogenesis regulation. Modifications of ECM composition and mechanical properties during carcinogenesis are critical for tumor initiation and progression. The core matrisome consists of five classes of macromolecules, which are collagens, laminins, fibronectin, proteoglycans, and hyaluronans. In most tissues, fibrillar collagen is the major component of ECM. Cells embedded into fibrillar collagen interact with it through their surface receptors, such as integrins and discoidin domain receptors (DDRs). On the one hand, cells incorporate signals from ECM that modify their functionalities and behaviors. On the other hand, all cells within tumor environment (cancer cells, cancer-associated fibroblasts, endothelial cells, and immune cells) synthesize and secrete matrix macromolecules under the control of multiple extracellular signals. This cell-ECM dialog participates in a dynamic way in ECM formation and its biophysical and biochemical properties. Here, we will review the functional interplay between cells and collagen network within the tumor microenvironment during colorectal cancer progression.

Highlights

  • Specialty section: This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology

  • Cells embedded into fibrillar collagen interact with it through their surface receptors, such as integrins and discoidin domain receptors (DDRs)

  • The most studied type I collagen receptors are integrins α1β1, α2β1, α10β1, and α11β1 [16]. These receptors can be activated by several ligands such as type I collagen after recognition of its GFOGER sequence [17]. α1β1 dimer was considered as the most expressed receptor in colon carcinoma [18]. β1-integrin expression in tumors was correlated with reduced overall survival and reduced disease-free survival in a large cohort of colorectal cancer (CRC) patients [19]

Read more

Summary

THE RELATIONSHIP BETWEEN COLLAGEN AND CANCER CELLS

Analysis of ECM signatures in patients’ colon tumors has revealed that type I collagen is highly expressed [5]. Concerning the role of type I collagen receptors in tumor progression, Roche’s group has elegantly recently shown that DDR1 plays a crucial role in the invasion function of metastatic colon carcinoma [28, 29]. Genes induced in CRC CAFs, compared to normal colonic fibroblasts, include several tumor-promoting MMPs and TGF-β1 increased Collagen I and various proteases expression by CAFs [56,57,58]. FAP-α activity has a strong impact on fibroblast secretome composition, including matrix processing enzymes, and influence morphology and collagen contraction capacity of immortalized CRC CAFs. Recent studies established a direct link between CAFs and the modifications of ECM organization and stiffness described in colon cancer. Another study reported that fibroblasts activated by latestage CRC cell-derived exosomes became specialized in type I collagen and physical remodeling of ECM through cytoskeletal re-organization, membrane protrusion formation, and secretion of matrix-remodeling proteins [65]

THE RELATIONSHIP BETWEEN COLLAGEN AND ENDOTHELIAL CELLS
IN VITRO TME MODELS USING COLLAGEN
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call